Research graph
References from When a Psychiatric Diagnosis Is Actually Perimenopause. Local targets link to admitted publications; unresolved targets remain external evidence.
Management of menopausal symptoms: a review
10.1001/jama.2022.24140 · 2023 · External reference
The 2022 hormone therapy position statement of the North American Menopause Society
10.1097/gme.0000000000002028 · 2022 · External reference
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging
10.1097/gme.0b013e31824d8f40 · 2012 · External reference
The 2023 practitioner's toolkit for managing menopause
10.1080/13697137.2023.2258783 · 2023 · External reference
Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives
10.1016/j.maturitas.2024.108087 · 2024 · External reference
A systematic review and critical appraisal of menopause guidelines
10.1136/bmjsrh-2023-202099 · 2024 · External reference
Estrogen—a key neurosteroid in the understanding and treatment of mental illness in women
10.1016/j.psychres.2022.114991 · 2023 · External reference
The impact of estradiol on serotonin, glutamate, and dopamine systems
10.3389/fnins.2024.1348551 · 2024 · External reference
Sleep health challenges among women: insomnia across the lifespan
10.3389/frsle.2024.1322761 · 2024 · External reference
Relationship of day-to-day reproductive hormone levels to sleep in midlife women
10.1001/archinte.165.20.2370 · 2005 · External reference
Factors influencing sleep disorders in perimenopausal women: a systematic review and meta-analysis
10.3389/fneur.2025.1460613 · 2025 · External reference
The risk of depression in the menopausal stages: a systematic review and meta-analysis
10.1016/j.jad.2024.04.041 · 2024 · External reference
Promoting good mental health over the menopause transition
10.1016/s0140-6736(23)02801-5 · 2024 · External reference
The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: a hypothesis paper
10.1016/j.psyneuen.2021.105418 · 2021 · External reference
Management of perimenopausal and menopausal symptoms
10.1136/bmj-2022-072612 · 2023 · External reference
Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review
10.1177/10398562231165439 · 2023 · External reference
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial
10.1001/jama.288.3.321 · 2002 · External reference
The Women's Health Initiative randomized trials and clinical practice: a review
10.1001/jama.2024.6542 · 2024 · External reference
The 2023 nonhormone therapy position statement of the North American Menopause Society
10.1097/gme.0000000000002200 · 2023 · External reference
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
10.1016/s0140-6736(23)00085-5 · 2023 · External reference
International versions of the Menopause Rating Scale (MRS)
10.1186/1477-7525-1-28 · 2003 · External reference
A factor analytic study of climacteric symptoms
10.1016/0022-3999(76)90005-2 · 1976 · External reference
